Morgan Philbin, PhD, MHS

Dr. Philbin is a social and behavioral scientist who uses mixed methods to examine how social policies and clinical practice shapes health outcomes with a focus on substance use and HIV/AIDS. She has worked in this field for over 15 years conducting research that explores how community-, institutional-, and state-level factors drive health outcomes among youth and young adults and pregnant people. Dr. Philbin completed her MHS and PhD at the Johns Hopkins Bloomberg School of Public Health, and her Postdoctoral Fellowship in HIV Center for Clinical and Behavioral Studies at Columbia University.

She is Co-PI of a mixed-methods NIDA-funded R01 that is exploring the impact of general and pregnancy-specific opioid policies on substance use and substance use treatment engagement among pregnant people and their newborns. She is also PI of an R34 that is developing a patient decision aid to help women and providers choose between oral and long-acting injectable HIV medication and Co-PI on a CDC-funded study on how women in the south engage with long-acting forms of HIV medication. She is Co-I on multiple NIH-funded projects, including a grant focused on substance use outcomes and criminal justice involvement, an R01 exploring how state-level social policies impact substance use outcomes for youth and another on state-level social policies and substance use outcomes among parenting women. She was awarded the 2021 NIH Office of Disease Prevention Early Stage Investigator Lecture Award for her work on HIV treatment and prevention.